CDC is in negotiations with Bavarian Nordic, a biotechnology firm based in Hellerup, Denmark, to obtain 200,000 doses of the company’s two-dose mpox vaccine, Kaseya announced at a briefing on 8 August. But that’s a far cry from the 10 million doses that the Africa CDC estimates are needed to...